New discussion-Pharmacogenomics of epilepsy

[Guest guest]

Hello,

We are coming up with the discussion-"Pharmacogenomics of epilepsy" which will be moderated by Dr Sandeep Kaushal from Ludhiana, Punjab, India.He will be moderating from 14th March to 19th March 2011.Welcome Sandeep, and please take over from tomorrow.

kunda

[Guest guest]

Hi,I am Sandeep from Ludhiana with interest in Epilepsy. We shall discuss the " Pharmacogenomics of epilepsy " .  Epilepsy is a common neurological disorder with a prevalence rate of about 1% and constitutes an important health care need of the country. It is disease mired with myths regarding its etiologies and treatment. It is one of diseases associated with stigma. In this present era of genomics the therapy can be guided with inputs from genomics to control the seizures in patients with epilepsy and guide the pharmacotherapy. Genomics play an important role in selecting an appropriate drug for the patient, modifying the pharmacokinetics and pharmacodynamics and hence overall response. It can also predict serious and severe ADRs with Anti-epileptic drugs and hence they can be avoided/prevented.

  We will discuss the various aspects one by one. Let us do it to make optimal utilization of knowledge and resources at hand to increase our knowledge and understand the practicalities of the advances in science.

Sandeep

On Sun, Mar 13, 2011 at 10:29 PM, kunda gharpure <gharpurekunda@...> wrote:

 

Hello,

We are coming up with the discussion- " Pharmacogenomics of epilepsy " which will be moderated by Dr Sandeep Kaushal from Ludhiana, Punjab, India.He will be moderating  from 14th March to 19th March 2011.Welcome Sandeep, and please take over from tomorrow.

kunda

-- Dr Sandeep Kaushal MD, MAMSAssistant Dean AcademicsProfessor and Head,

Department of  PharmacologyConsultant, Comprehensive Epilepsy Care ClinicPrincipal Investigator, Clinical Pharmacology Unit,

Member Secretary IEC and IAEC

Dayanand Medical College & Hospital,Ludhiana, Punjab, India-141001Tel: +91 161 276 0470 ®;       +91 161 4686613 (O)Fax: +91 161 247 2620;Mob: +91 98766 35367